The U.S. Federal Trade Commission (FTC) has sued telehealth platform Hims & Hers, alleging the company shared users' sensitive health information with online advertisers like Meta Platforms and Snap, despite promising privacy. The lawsuit also claims Hims & Hers engaged in deceptive billing practices, charging users for prescriptions before consultations, and made it difficult to cancel subscriptions. Hims & Hers has called the claims baseless. Following the news, Hims & Hers stock fell approximately 12%.